Submission Preparation ChecklistAs part of the submission process, authors are required to check off their submission's compliance with all of the following items, and submissions may be returned to authors that do not adhere to these guidelines.
- I declare that all authors had a substantial contribution to the manuscript.
- I declare that all authors approved the final version of the manuscript.
- I declare that the manuscript is not under review in any other journal, and that has not been published in part or in whole in another journal.
I declare that the manuscript was not submitted before. If part has been presented at a conference, indicate on the title page the name, location and conference dates.
- I declare that the article is original, that all statements presented as facts are based on research of the authors, who are responsible for it.
- I declare that the manuscript, or in part to the whole, does not violate any copyright and does not violate any rights of privacy of patients.
- I declare that there isn't on the part of the authors conflict of interest on statements made on this work.
- Authors declare that by submitting the work for publication, share the copyright to the SPDV Journal.
- All authors and contributors must include their ORCID Identifier.
Before you Begin
The title (and abstract and key words if applicable) must be submitted in both English and Portuguese.
Articles submitted to the Journal should be clearly written in English.
Submissions that do not conform to these instructions may be returned for reformulation and resubmission.
All articles in this journal are Open Access and meet the requirements of funding bodies or academic institutions. Each article published in the Journal is published under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0). Articles can be read, downloaded, printed, and shared.
Submission of an article for publication implies the authors’ consent to publication under the applicable Creative Commons license and the terms and conditions of the Publisher’s Licensing Agreement.
It is the author's responsibility to obtain permission to reproduce illustrations, tables, etc. from other publications.
Upon acceptance of an article, authors will be asked to complete a 'Journal Publishing Agreement'. An e-mail will be sent to the corresponding author confirming receipt of the manuscript together with a 'Journal Publishing Agreement' form or a link to the online version of this agreement.
Author rights: As an author you (or your employer or institution) have certain rights to reuse your work.
The Journal reserves the right to use plagiarism detection software on any submitted material.
Article Processing Charges
There is no Article Processing Charge (APC) or Article Submission Charge.
It is permitted to authors of Open Access articles to post the final, published version of their article in Open Access repositories or on other websites, in accordance with the Creative Commons license.
Submission of a manuscript to the J Port Soc Dermatol Venereol implies that all authors have read and agreed to its content and that the manuscript conforms to the journal’s policies.
Manuscripts submitted for publication should be prepared in accordance with the “Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals” of the International Committee of Medical Journal Editors (ICMJE), updated in December 2015. This document is available at http://www.icmje.org/recommendations/.
The Journal supports COPE (the Committee on Publication Ethics), which provides a forum for publishers and editors of scientific journals to discuss issues relating to the integrity of the work submitted to or published in their journals.
Standards of Reporting
The Journal advocates complete and transparent reporting of biomedical and biological research. We strongly recommend that authors adhere to the guidelines on data reporting established by the Enhancing the QUAlity and Transparency Of health Research (EQUATOR) network (http://www.equator-network.org). Checklists are available for a number of study designs, including:
- Randomized controlled trials (CONSORT)
- Systematic reviews and meta-analyses* (PRISMA) and protocols (PRISMA-P)
- Observational studies (STROBE)
- Case reports (CARE)
- Qualitative research (COREQ)
- Diagnostic/prognostic studies (STARD )
- Economic evaluations (CHEERS)
- Pre-clinical animal studies (ARRIVE)
- Clinical Practice Guidelines (AGREE)
- Quality improvement studies (SQUIRE)
- Study protocols (SPIRIT)
*Authors of systematic reviews should also provide a link to an additional file from the ‘methods’ section, which reproduces all details of the search strategy.
The acceptance criteria for all papers are the quality and originality of the research and its significance to our readership. Except where otherwise stated, manuscripts are single-blind peer reviewed by two anonymous reviewers and the Editor. Final acceptance or rejection rests with the Editor, who reserves the right to refuse any material for publication.
Manuscripts should be written in a clear, concise, direct style, so that they are intelligible to the professional reader who is not a specialist in the particular field. Where contributions are judged as acceptable for publication on the basis of scientific content, the Editor and the publisher reserve the right to modify typescripts to eliminate ambiguity and repetition and improve communication between author and reader. If extensive alterations are required, the manuscript will be returned to the author for revision.
Manuscripts that do not comply with the instructions for authors may be returned for modification before being reviewed.
To give appropriate credit to each author, the individual contributions of authors should be specified in the manuscript.
The Journal defines an author as a person who has made substantive intellectual contributions to a published study to take public responsibility for it.
We recommend that the authors adhere to the authorship criteria of the International Committee of Medical Journal Editors (ICMJE). According to the ICMJE guidelines, to qualify as an author one should have:
- Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; AND
- Drafting the work or revising it critically for important intellectual content; AND
- Final approval of the version to be published; AND
- Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
Acquisition of funding, collection of data, or general supervision of the research group, alone, does not usually justify authorship.
Any person who does not meet all four of the listed criteria does not qualify as an author and should not be designated as such. The final author line up and order should be determined by all authors before submission and may not be changed without a written explanation and signed permission of all authors.
Each manuscript must have a corresponding author, who assumes full responsibility for the integrity of the submission as a whole, from inception to published article. The Journal reserves the right to clarify each author’s role, based on information collected from authors in connection with their submission.
Acknowledgements: All contributors who do not meet the criteria for authorship should be listed (with their written permission) in an ‘Acknowledgements’ section with a description of their individual contributions. This requirement covers any editorial or authorship contributions made on behalf of outside organizations, persons, funding bodies, or persons hired by funding bodies.
Role of the Funding Source: All sources of funding should be declared as an acknowledgment at the end of the text. At the end of the Methods section, under a subheading "Role of the funding source", authors must describe the role of the study sponsor(s), if any, in study design; in the collection, analysis, and interpretation of data; in the writing of the report; and in the decision to submit the paper for publication. If there is no Methods section, the role of the funding source should be stated as an acknowledgment. If the funding source(s) had no such involvement then this should be stated.
Role of Medical Writer: When medical writers or editing services were used, their activities should be acknowledged, along with their source funding source. This information should be added to the Acknowledgments section. We require signed statements from any medical writers or editors declaring that they have given permission to be named in the Acknowledgments section.
The corresponding author will be the link withh the editorial team on behalf of all co-authors during the submission and review process. Any of the authors, but a single one, can be the corresponding author.
The corresponding author will comply with the requirements of submission and certifies that all authors have read and approved the final version of the manuscript and is responsible for filling formulars concerning authors' COI.
The corresponding author informs the other authors on the decisions, reviewer's comments and other messagers from the Journal, and send corrections, certifying that authors have approved the final version of the manuscript.
The Journal of SPDV requests that all authors submit their ORCID (Open Researcher and Contributor ID) with the manuscript.
In order to get more information and to register your ORCID visit ORCID.org (https://orcid.org/content/collect-connect)
Patient and Other Consents
Appropriate written consents, permissions, and releases must be obtained where you wish to include any case details, personal information, and/or images of patients or other individuals in the J PORT SOC DERMATOL VENEREOL in order to comply with all applicable laws and regulations concerning privacy and/or security of personal information. Studies on patients or volunteers need approval from an ethics committee and informed consent from participants. These should be documented in your paper.
"Blackout" bars or similar devices do not anonymise patients in clinical images: appropriate consent is needed.
Duplicate Submission and Publication
J PORT SOC DERMATOL VENEREOL does not accept material previously published in printed or electronic form or manuscripts under consideration by another journal.
J PORT SOC DERMATOL VENEREOL endorses the policies of the ICMJE in relation to overlapping publications
Whether intentional or not, plagiarism is a serious violation. We define plagiarism as reproduction of another work with at least 25% similarity and without citation. If evidence of plagiarism is found before/after acceptance or after publication of the paper, the author will be offered a chance for rebuttal. If the arguments are not found to be satisfactory, the manuscript will be retracted and the author sanctioned from publishing papers for a period to be determined by the Editor.
At the external peer review stage you will need to send signed copies of the following statements:
- Authors' contributions
- Conflicts of interest statements
- Acknowledgments — written consent of cited individual
- Personal communications — written consent of cited individual
- Use of copyright-protected material — signed permission statements from author and publisher
If the work involves the use of animal or human subjects, the author should ensure that the work described has been carried out in accordance with The Code of Ethics of the World Medical Association (Declaration of Helsinki) for experiments involving humans http://www.wma.net/en/30publications/10policies/b3/index.html; EU Directive 2010/63/EU for animal experiments http://ec.europa.eu/environment/chemicals/lab_animals/legislation_en.htm; Uniform Requirements for manuscripts submitted to Biomedical journals http://www.icmje.org. Authors should include a statement in the manuscript that informed consent was obtained for experimentation with Human subjects. The privacy rights of human subjects must always be observed.
Publication of patient data and photographs must not enable the institution or individuals involved to be identified unless accompanied by written permission for their use from the individuals concerned.
For studies involving patients, a statement must be included to the effect that the study was conducted in accordance with the amended Declaration of Helsinki, that the local institutional review board or independent ethics committee approved the protocol, and that written informed consent was obtained from all patients. The name of the committee, the name of the chairperson of the committee (or the person who approved the protocol), the date of approval and the approval number should follow this statement in the Methods section. For multicentre studies, a list of the relevant approvals may be provided in a separate document to be published as supplementary material.
The text, tables, figures, and supplementary data of submitted manuscripts must not contain any details identifying patients or study participants, including names, initials, date of birth, Social Security numbers, dates, or medical record numbers, unless written informed permission has been obtained from the patient, guardian, or next of kin and copies provided to the Journal prior to publication.
If photographs of patients are used, they must be accompanied by written permission for reproduction or must not enable the patient to be identified. Identifying details should be omitted if they are not essential, but patient data should never be altered or falsified in an attempt to attain anonymity.
Informed Consent and Patient Details
Studies on patients or volunteers require ethics committee approval and informed consent, which should be documented in the paper. Appropriate consents, permissions and releases must be obtained where an author wishes to include case details or other personal information or images of patients and any other individuals. Written consents must be retained by the author and copies of the consents or evidence that such consents have been obtained must be provided. Unless you have written permission from the patient (or, where applicable, the next of kin), the personal details of any patient included in any part of the article and in any supplementary materials (including all illustrations and videos) must be removed before submission.
All previously published and copyrighted material, including illustrations, diagrams and tables, must be accompanied by written permission for reproduction from the copyright holders.
Conflict of Interest
A conflict of interest exists when professional judgement concerning a primary interest may be influenced by a secondary interest (such as financial gain). Financial relationships are easily identifiable, but conflicts can also occur because of personal relationships or rivalries, academic competition, or intellectual beliefs (examples of potential conflicts of interest include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other funding). All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence (bias) their work. All authors must disclose, in the cover letter, any actual or potential conflict of interest.
If there are no conflicts of interest then please state this: 'Conflicts of interest: none'.
Failure to disclose conflicts might lead to publication of a correction or even to retraction.
Clinical Trial Results
J PORT SOC DERMATOL VENEREOL supports initiatives to improve reporting of clinical trials. This includes prospective registration of clinical trials in suitable publicly available databases. In line with ICMJE guidelines, J PORT SOC DERMATOL VENEREOL requires registration of all clinical trials that are reported in manuscripts submitted to its journals.
The ICMJE uses the World Health Organization (WHO) definition of a clinical trial, which is "any research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects on health outcomes". This definition includes phase I to IV trials. The ICMJE defines health-related interventions as "any intervention used to modify a biomedical or health-related outcome" and health-related outcomes as "any biomedical or health-related measures obtained in patients or participants".
Registration of Clinical Trials
Registration in a public trials registry is a condition for publication of clinical trials in this journal in accordance with International Committee of Medical Journal Editors (ICMJE, http://www.icmje.org) recommendations. Trials must register at or before the onset of patient enrolment. The clinical trial registration number should be included at the end of the abstract of the article. A clinical trial is defined as any research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects of health outcomes. Health-related interventions include any intervention used to modify a biomedical or health-related outcome (for example drugs, surgical procedures, devices, behavioral treatments, dietary interventions, and process-of-care changes). Health outcomes include any biomedical or health-related measures obtained in patients or participants, including pharmacokinetic measures and adverse events. Purely observational studies (those in which the assignment of the medical intervention is not at the discretion of the investigator) will not require registration.
The trial registration number (TRN) and date of registration should be included as the last line of the manuscript abstract.
Registration of Systematic Reviews
J PORT SOC DERMATOL VENEREOL supports the prospective registration of systematic reviews and encourages authors to register their systematic reviews in a suitable registry (such as PROSPERO). Authors who have registered their systematic review should include the registration number as the last line of the manuscript abstract.
Availability of Data
J PORT SOC DERMATOL VENEREOL strongly encourages that all datasets on which the conclusions of the paper rely should be available to readers. We encourage authors to ensure that their datasets are either deposited in publicly available repositories (where available and appropriate) or presented in the main manuscript or additional supporting files, in machine-readable format (such as spreadsheets rather than PDFs) whenever possible. We require a data sharing statement at the end of every research manuscript. For trials of drugs or devices the statement must state, at a minimum, that the relevant anonymized patient level data are available on reasonable request from the authors.
Options for formatting the statement are suggested here:
"Data sharing: patient level data [and/or] full dataset [and/or] technical appendix [and/or] statistical code [and/or] available at [/doi] [with open access/with these restrictions] [from the corresponding author at ]. Participants gave informed consent for data sharing [or ... consent was not obtained but the presented data are anonymized and risk of identification is low ... or consent was not obtained but the potential benefits of sharing these data outweigh the potential harms because ...]"
If no such further data are available, please use this wording: "Data sharing: no additional data available."
This option is not available for trials of drugs or devices.
Authors may be required to provide the raw data for research papers when they are under review and up to 10 years after publication.
Submission of an article implies that the work described has not been published previously (except in the form of an abstract or as part of a published lecture or academic thesis or as an electronic preprint, that it is not under consideration for publication elsewhere, that its publication is approved by all authors and tacitly or explicitly by the responsible authorities where the work was carried out, and that, if accepted, it will not be published elsewhere in the same form, in English or in any other language, including electronically.
All manuscripts must be accompanied by a cover letter. Assurance should be given in the cover letter that the manuscript is not under simultaneous consideration by any other publication. In the cover letter, the authors should declare their potential conflicts of interest and provide a statement on authorship.
To verify originality, your article may be checked by the originality detection service.
Submit your article
Please submit your article via https://revista.spdv.com.pt
In case of problems with submission, please contact:
Dermatology Department, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal
Use of word processing software
It is important that the file be saved in the native format of the word processor used. The text should be in single-column format. Keep the layout of the text as simple as possible.
To avoid unnecessary errors you are strongly advised to use the 'spell-check' and 'grammar-check' functions of your word processor.
J PORT SOC DERMATOL VENEREOL accepts the following publication types:
a) Original articles reporting clinical or basic research (clinical trials, cohort studies, case-control studies, observational studies)
b) Review articles (including systematic reviews and meta-analyses) of clinical or basic-science topics;
c) Clinical Case Studies/Case Reports;
d) Short reports on clinical or basic studies
e) Images in Dermatology;
f) Editorials, which are written at the invitation of the Editor and consist of commentary on articles published in the journal or on subjects of particular relevance;
g) Letters to the Editor, which consist of concise opinions on recently published articles;
h) In Memorium
Authors should indicate in the cover letter which manuscript type is being submitted for publication
Title page information
The title should be given in both Portuguese and English and should be concise, informative, contain no abbreviations and not exceed 120 characters. The title may include a subtitle with a maximum of 40 characters (including spaces).
II. Author names and affiliations
Where the family name may be ambiguous (e.g., a double name), please indicate this clearly. Present the authors’ affiliation addresses (where the actual work was done) below the names. Indicate all affiliations with a lower-case superscript letter immediately after the author’s name and in front of the appropriate address. Provide the full postal address of each affiliation, including the country name and, if available, the e-mail address of each author.
All entities that sponsored the work should be listed.
IV. Corresponding author.
Clearly indicate who will handle correspondence at all stages of refereeing and publication, also post-publication. Ensure that phone numbers (with country and area code) are provided in addition to the e-mail address and the complete postal address. Contact details must be kept up to date by the corresponding author.
Present/permanent address. Ensure that the e-mail address is given and that contact details are kept up to date by the corresponding author.
Present/permanent address. If an author has moved since the work described in the article was done, or was visiting at the time, a 'Present address' (or 'Permanent address') may be indicated as a footnote to that author's name. The address at which the author actually did the work must be retained as the main, affiliation address. Superscript Arabic numerals are used for such footnotes.
V. Abstract and Keywords
A concise and factual abstract is required. An abstract is often presented separately from the article, so it must be able to stand alone. The abstract must be written in both Portuguese and English. It should not contain abbreviations, references, or footnotes.
At the end of the abstract, a maximum of six keywords must be included, using the terminology appearing in “Medical Subject Headings (MeSH)” (http://www.nlm.nih.gov/mesh/meshhome.html).
VI. Structured Abstract
A structured abstract, by means of appropriate headings, should provide the context or background for the research and should state its purpose, basic procedures (selection of study subjects or laboratory animals, observational and analytical methods), main findings (giving specific effect sizes and their statistical significance, if possible), and principal conclusions. It should emphasize new and important aspects of the study or observations. The Introduction, Methods, Results and Conclusions will be followed.
VII. In original and review articles or case report a small text (no longer than 250 characters) should be added with "What does this study add" to be highlighted in the publication.
VIII. The authors will also include in this title page, under the heading “Ethical disclosures” their statement on the Protection of human and animal subjects, the Confidentiality of Data, and the Right to privacy and informed consent.
The authors will mandatorily include one of the texts shown below for each one of the sections, depending on the characteristics of their article/research.
PROTECTION OF HUMAN SUBJECTS AND ANIMALS IN RESEARCH:
Protection of human and animal subjects. The authors declare that no experiments were performed on humans or animals for this investigation.
Protection of human and animal subjects. The authors declare that the procedures followed were in accordance with the regulations of the responsible Clinical Research Ethics Committee and in accordance with those of the World Medical Association and the Helsinki Declaration.
PATIENTS’ DATA PROTECTION:
Confidentiality of Data. The authors declare that they have followed the protocols of their work center on the publication of patient data and that all the patients included in the study have received sufficient information and have given their informed consent in writing to participate in that study.
Confidentiality of Data. The authors declare that no patient data appears in this article.
RIGHT TO PRIVACY AND INFORMED CONSENT:
Right to privacy and informed consent. The authors have obtained the informed consent of the patients and/or subjects mentioned in the article. The author for correspondence is in possession of this document.
Right to privacy and informed consent. The authors declare that no patient data appears in this article
Prizes and previous presentations
The authors should refer previous prizes and/or presentations of the study prior to manuscript submission.
Original articles are fully documented reports of original clinical or basic research that must describe full sets of interesting, original experiments in current research. Original articles should include the following sections: Introduction, Materials and Methods, Results, Discussion and Conclusions, Acknowledgements (if applicable), References, Tables and Figures.
Original articles should not exceed 4000 words, excluding up to 6 tables or figures and up to 60 references, a brief text no longer than 250 characters with "What does the study add?" and a structured abstract up to 350 words.
Introduction: State the objectives of the work and provide an adequate background, avoiding a detailed literature survey or a summary of the results.
Material and methods: Provide sufficient detail to allow the work to be reproduced. Methods already published should be indicated by a reference: only relevant modifications should be described.
Results: Results should be clear and concise.
Discussion: This should explore the significance of the results of the work, not repeat them. A combined Results and Discussion section is often appropriate. Avoid extensive citations and discussion of published literature.
Conclusions: The main conclusions of the study may be presented in a short Conclusions section, which may stand alone or form a subsection of a Discussion or Results and Discussion section.
Review Articles are comprehensive papers that synthesize older ideas and suggest new ones. They cover broad areas. They may be clinical, investigational, or basic science in nature. Although usually commissioned, we do occasionally accept unsolicited review articles on important and topical subjects with a particular focus on recent advances. Before submitting a review, we ask that you send the editors a brief outline (no more than 500 words) indicating the importance and novelty of the subject, and why you are qualified to write it. An invitation to submit does not guarantee acceptance.
Review articles should not exceed 4000 words, excluding up to 6 tables or figures and up to 100 references. An unstructured abstract up to 350 words and a brief text no longer than 250 characters with "What does the study add?" are needed.
Systematic Reviews can be presented in the Introduction, Methods, Results, Discussion format. The subject must be clearly defined. The objective of a systematic review should be to produce an evidence-based conclusion. Methods should give a clear indication of the literature search strategy, data extraction, grading of evidence and analysis. We strongly encourage authors to comply with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines (http://www.prisma-statement.org/).
Systematic review articles should not exceed 4000 words, excluding up to 6 tables or figures and up to 100 references. Structured abstract up to 350 words and a brief text no longer than 250 characters with "What does the study add?" are needed.
Clinical Case Studies/Case Reports
Clinical Case Reports should include the following sections: Introduction, Clinical Case, and Discussion and a brief text no longer than 250 characters with "What does the study add?" and an unstructured abstract up to 150 words. Clinical case studies should not exceed 2000 words excluding up 25 references.
We strongly encourage authors to comply with the CARE guidelines (http://www.care-statement.org/).
Short Reports on clinical, basic or translational investigation
Editorials are normally written at the invitation of the Editor and consist of commentary on articles published in the journal or on subjects of particular relevance. Editorials should not exceed 1200 words and 15 references and may include 1 table and 1 figure. Abstract is not required.
Letters to the Editor
Letter to the Editor should consist of critical comments on an article published in the Journal or a short note on a particular topic or clinical case. Letters to the Editor should not exceed 600 words and 10 references and may contain one figure or table. Abstract is not required.
Images in Dermatology
This section is intended for the publication of clinical, radiological, histological, and surgical images related to dermatology and venereology.
Title should be no more than eight words. Authors should be no more than four. Images should be of high quality and educational value. Up to four figures will be published. Captions should be brief and informative. The text should not exceed 500 words, up to five references, and should include a short clinical history and relevant data from the physical examination, laboratory tests, and clinical progression as appropriate. Abstract is not required.
Quiz in Dermatology
This section is intended for the publication of clinical, radiological, histological, and surgical images that may be very relevant to establish a diagnosis in dermatology and venereology. Clinical data and photos should be concise to be included in a single page and enough to stimualte the reader to formulate a diagnostic hypothesis, that will be further discussed in a next page.
Title should be no more than eight words. Authors should be no more than four. Images should be of high quality and educational value. Up to four figures will be published. Captions should be brief and informative. Arrows or other symbols should be included as needed to facilitate understanding of the images. The text should not exceed 500 words, up to five references, and should include a short clinical history and relevant data from the physical examination, laboratory tests, and clinical progression as appropriate. Abstract is not required.
Original and concise article, written by invitation that approaches historical aspects of dermatologic interest, such as commemorations of outstanding events in the progress of medicine and particularly dermatology, biographies and commemorations regarding relevant personalities in national and international dermatology. The organization of the text is free, however it should not exceed 800 words, excluding illustrations and references that are limited to two and ten, respectively.
Main text structure
Max. 350 words; structured (Introduction and Objectives, Methods, Results and Conclusion)
Portuguese and English
Up to 6
Portuguese and English
Introduction; Methods; Results; Discussion; Conclusion; Acknowledgments, if any; References; and figure legends, if any
Total up to 6
Up to 60
Max. 350 words; unstructured Portuguese and English
Up to 6
Portuguese and English
Introduction; thematic sections at the discretion of the authors; Conclusion; Acknowledgments, if any; References; and figure legends, if any
Total up to 6
Up to 100
Max. 350 words; structured
Portuguese and English
Up to 6
Portuguese and English
Total up to 6
Up to 100
Max. 150 words; unstructured Portuguese and English
Up to 6 Portuguese and English
Introduction; Case report; Discussion; Conclusion (optional); References; and figure legends, if any
Total up to 4
Up to 25
Images in Dermatology
Up to 6 Portuguese and English
Total up to 4
Up to 5
What’s your diagnosis?
Up to 6 Portuguese and English
Total up to 4
Up to 5
Total up to 2
Up to 15
Letter to the Editor
Up to 6 Portuguese and English
Total up to 1
Up to 8
I.Citation in text
Please ensure that every reference cited in the text is also present in the reference list (and vice versa). The references should be listed using Arabic numerals in the order in which they are cited in the text.
References to personal communications and unpublished data should be made directly in the text and should not be numbered. Citation of a reference as 'in press' implies that the item has been accepted for publication. Journal names should be abbreviated according to Medline style.
References to articles published in journals should include the first author’s name (surname and given name) followed by the names of the remaining authors, the article title, the journal name, and the publication year, volume, pages and the DOI.
Increased discoverability of research and high quality peer review are ensured by online links to the sources cited. Please ensure that data provided in the references are correct. Please note that incorrect surnames, journal/book titles, publication year and pagination may prevent link creation. When copying references, please be careful as they may already contain errors.
The references list should be added as part of the regular text, never as a footnote. Specific codes from reference-management software are not acceptable.
A detailed description of the formats of different reference types can be found in the “Uniform Requirements for Manuscripts Submitted to Biomedical Journals” (http://www.nlm.nih.gov/bsd/uniform_requirements.html). Selected examples are given below.
List all authors if there are six or fewer; et al. should be added if there are more than six authors. Article title, journal name, year, volume, and pages.
Reference Management Software: The use of EndNote is recommended to facilitate formatting of citations and reference lists. The journal output style can be downloaded from http://endnote.com/downloads/styles.
III. Reference style
Text: Indicate references by number(s) in superscript in line with the text. The actual authors can be referred to, but the reference number(s) must always be given.
List: Number the references in the list in the order in which they appear in the text.
Name(s) and initials of author(s). Article title. Journal name Year; Volume: Page(s). doi
Should the article have several authors, mention six of them at most; if there are more, list the first six followed by "et al"
Less than 6 authors
Canelas MM, Cardoso JC, Gonçalo M, Figueiredo A. Photoallergic contact dermatitis from benzydamine presenting mainly as lip dermatitis. Contact Dermatitis. 2010;63:85-8. doi: 10.1111/j.1600-0536.2010.01707.x.
More than 6 authors
Francisco V, Neves BM, Cruz MT, Gonçalo M, Figueiredo A, Duarte CB, et al. Effect of lipopolysaccharide, skin sensitizers and irritants on thioredoxin-1 expression in dendritic cells: relevance of different signalling pathways. Arch Dermatol Res. 2010 ;302:271-82. doi: 10.1007/s00403-009-0993-z
Name(s) and initials of author(s)/Editors. Book title. Edition. City: Name of publisher: year of publication. page(s).
Atlas SW. Magnetic resonance imaging of the brain and spine. 3rd ed. Philadelphia: Lippincott Williams & Wilkins; 2004.
Coleman WP, Lawrence N, editors. Skin resurfacing. Baltimore: Williams and Wilkins; 1998.
Chapter in Book:
Name(s) and initials of author(s) of chapter. Chapter title. In: Name(s) and initials of editor(s). Book title. City: Name of publisher, year of publication: pages.
Gasparro F, Edelson RL. Extracorporeal photochemotherapy. In: Krutmann J, Elmets CA, editors. Photoimmunology. Oxford: Blackwell Scientific; 1995. p.231-45.
Borkowski MM. Infant sleep and feeding: a telephone survey of Hispanic Americans [dissertation]. Mount Pleasant: Central Michigan University; 2002.
Scientific and technical report
Lugg DJ. Physiological adaptation and health of an expedition in Antarctica: with comment on behavioural adaptation. Canberra: AGPS; 1977. Australian Government Department of Science, Antarctic Division. ANARE scientific reports. Series B(4), Medical science No. 0126
Anderson SC, Poulsen KB. Anderson's electronic atlas of hematology [CD-ROM]. Philadelphia: Lippincott Williams & Wilkins, 2002.
2. Online Book
Van Belle G, Fisher LD, Heagerty PJ, Lumley TS. Biostatistics: a methodology for the health sciences [e-book]. 2nd ed. Somerset: Wiley InterScience; 2003 [cited 2005 Jun 30]. Available from: Wiley InterScience electronic collection
Cancer-Pain.org [homepage on the Internet]. New York: Association of Cancer Online Resources, Inc.; c2000-01 [updated 2002 May 16; cited 2002 Jul 9]. Available from: http://www.cancer-pain.org/
Note shortened form for last page number. e.g., 51–9, and that for more than 6 authors the first 6 should be listed followed by 'et al.' For further details you are referred to 'Uniform Requirements for Manuscripts submitted to Biomedical Journals' (see also http://www.nlm.nih.gov/bsd/uniform_requirements.html).
Footnotes should be avoided. When essential, they should be numbered consecutively and appear at the foot of the appropriate page.
Collate acknowledgements in a separate section at the end of the article before the references and do not, therefore, include them on the title page, as a footnote to the title or otherwise. List here those individuals who provided help during the research (e.g., providing language help, writing assistance or proof reading the article, etc.).
Abbreviations (with the exception of those clearly well-established in the field) should be explained when they are first used.
Define all abbreviations except those approved by the International System of Units for length, mass, time, temperature, amount of substance, etc. Do not create new abbreviations for drugs, procedures, experimental groups, etc.
Abbreviations or acronyms should not be used in the title and abstract, but only in the text and in a limited way. Abbreviations should be defined at first use, in full, followed by the abbreviation in parentheses. Excessive and unnecessary use of acronyms and abbreviations should be avoided. ((All this is checked by our copy editors))
Units of measurement
Follow internationally accepted rules and conventions: use the international system of units (SI).
Temperatures should be given in degrees Celsius (°C) and blood pressure in millimeters of mercury (mm Hg).
Use generic names of drugs (first letter: lowercase) whenever possible. Registered trade names (first letter: uppercase) should be marked with the superscript registration symbol ® or ™ when they are first mentioned.
Names of Genes, Symbols and access numbers
Genes and related structures should be given the official names and symbol of National Center for Biotechnology Information (NCBI) or the HUGO Gene Nomenclature Committee. Before submission of a manuscript with many genomic data (e.g., protein or DNA sequences ), data should be deposited in a Public Data Bank, like GenBank do NCBI, and a full access number should be given in the Methods section.
Tables and illustrations
Tables and figures must be numbered (e.g. Figure 1, Figure 2, Table 1) and submitted as separate files.
Captions should be numbered using Arabic numerals in the order in which they appear in the text (e.g., Table 1, Fig. 1) and must provide sufficient information to enable their interpretation without consulting the text.
Ensure that each illustration and table has a caption. Supply captions separately, not attached to the figure. A caption should comprise a brief title (not on the figure itself) and a description of the illustration. Keep text in the illustrations themselves to a minimum but explain all symbols and abbreviations used.
• Make sure you use uniform lettering and sizing of your original artwork.
• Embed the used fonts if the application provides that option.
• Aim to use the following fonts in your illustrations: Arial, Courier, Times New Roman, Symbol, or use fonts that look similar.
• Number the illustrations according to their sequence in the text.
• Use a logical naming convention for your artwork files.
• Provide captions to illustrations separately.
• Size the illustrations close to the desired dimensions of the published version.
• Submit each illustration as a separate file.
If your electronic artwork is created in a Microsoft Office application (Word, PowerPoint, Excel) then please supply 'as is' in the native document format.
Regardless of the application used other than Microsoft Office, when your electronic artwork is finalized, please 'Save as' or convert the images to one of the following formats (note the resolution requirements for line drawings, halftones, and line/halftone combinations given below):
EPS (or PDF): Vector drawings, embed all used fonts.
TIFF (or JPEG): Color or grayscale photographs (halftones), keep to a minimum of 500 dpi.
TIFF (or JPEG): Bitmapped (pure black & white pixels) line drawings, keep to a minimum of 1000 dpi.
TIFF (or JPEG): Combinations bitmapped line/half-tone (color or grayscale), keep to a minimum of 500 dpi.
Please do not:
• Supply files that are optimized for screen use (e.g., GIF, BMP, PICT, WPG); these typically have a low number of pixels and limited set of colors;
• Supply files that are too low in resolution;
• Submit graphics that are disproportionately large for the content.
Please submit tables as editable text and not as images. Tables can be placed either next to the relevant text in the article, or on separate page(s) at the end. Number tables consecutively in accordance with their appearance in the text and place any table notes below the table body. Be sparing in the use of tables and ensure that the data presented in them do not duplicate results described elsewhere in the article. Please avoid using vertical rules.
Multimedia files should be submitted in a separate file with the original manuscript and with all subsequent submissions. Multimedia material must meet production quality standards for publication without the need for any modification or editing. Acceptable files are MPEG, AVI or QuickTime formats.
If there is more than one appendix, they should be identified as A, B, etc. Formulae and equations in appendices should be given separate numbering: Eq. (A.1), Eq. (A.2), etc.; in a subsequent appendix, Eq. (B.1) and so on. Similarly for tables and figures: Table A.1; Fig. A.1, etc.
The following list will be useful during the final checking of an article prior to sending it to the journal for review.
Ensure that the following items are present:
One author has been designated as the corresponding author with contact details:
• E-mail address
• Full postal address
All necessary files have been uploaded, and contain:
• All figure captions
• All tables (including title, description, footnotes)
• Manuscript has been 'spell-checked' and 'grammar-checked'
• References are in the correct format for this journal
• All references mentioned in the Reference list are cited in the text, and vice versa
• Permission has been obtained for use of copyrighted material from other sources (including the Internet)
Style and Usage
J PORT SOC DERMATOL VENEREOL follows the American Medical Association Manual of Style (10th ed) in matters of editorial style and usage. All accepted manuscripts are subject to copyediting for conciseness, clarity, grammar, spelling, and AMA style. The corresponding author will receive page proofs to review before publication. If requests for changes are made after the authors have returned corrected proofs. Care should be exercised in this stage of review so as to avoid publication of errata or retractions.
Before submitting a manuscript to the Rev Soc Port Dermatol Venereol, authors must have in their possession the following documents that may be requested by the editorial board:
- Informed consent of each participant, if applicable;
- Informed consent regarding each individual present in photographs, even after trying to hide their identity
- Authorization to reproduce/use previously published material, to reproduce previously published illustrations;
- Declaration of approval by the ethics committees of the institutions involved, if applicable.
Copyright Sharing Statement
When the article is accepted for publication, it is mandatory to send a digitized document via e-mail, signed by all Authors, with the sharing of copyright between authors and Rev Soc Port Dermatol Venereol.
The Author (s) must sign a copy of copyright sharing between authors and the Rev Soc Port Dermatol Venereol when submitting the manuscript, according to the draft published in the annex.
Note: This signed document should only be sent when the manuscript is accepted for publication.
“Editor of the Revista da Sociedade Portuguesa de Dermatologia e Venereologia
The Author (s) certify that the manuscript entitled: ____________________________________________ (ref. SPDV________) is original, that all statements presented as facts are based on the investigation of the Author (s), that the manuscript, whether in part or in whole, it does not infringe any copyright and does not infringe any privacy right, which has not been published in part or in whole and which has not been submitted for publication, in whole or in part, in another journal, and which the Authors have the right to copyright.
All Authors also declare that they participated in the work, are responsible for it and that there is no conflict of interest on the part of any of the Authors in the statements made at work.
When submitting the work for publication, the Authors share with Rev Soc Port Dermatol Venereol all rights to the copyright interests of the article.
All Authors must sign
Name (capital letters): ______________________________
For a more complete explanation on this matter, it is advisable to read Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals (ICMJE Recommendations), available at http://www.ICMJE.org.
Last revision: May 2021
Continuous Medical Education
Artigos sobre temas de grande interesse científico, dermatológico, visando a actualização. O artigo deve conter obrigatoriamente: Resumo estruturado. O texto não deve exceder as 3.500 palavras, excluindo ilustrações e referências. Deve ter no mínimo 30 referências bibliográficas recentes, sendo permitidas no máximo 10 ilustrações. No final do texto deve ser incluído um teste com questões para avaliação do que aprendeu.
O texto deve ser apresentado com as seguintes secções: Introdução (incluindo Objectivos), Material e Métodos, Resultados, Discussão, Conclusões, Agradecimentos (se aplicável), Bibliografia, Quadros e Figuras.
Os Artigos Originais não deverão exceder as 4.000 palavras, excluindo referências e ilustrações. Deve ser acompanhado de ilustrações, com um máximo de 6 figuras/tabelas e 60 referências bibliográficas.
Manuscritos reportando estudos randomizados e controlados devem seguir o CONSORT Statement http://www.consort-statement.org/
Manuscritos reportando ensaios clínicos devem seguir os critérios do ICMJE http://www.icmje.org/.
Adesão ao QUORUM Statement (Quality of Reporting of Meta-analysis) e o ao STARD (Standards for Reporting of Diagnostic Accuracy), que guiam os autores sobre a informação que deve ser incluída para permitir que os leitores e revisores avaliarem o rigor e transparência da investigação
O relato de um caso clínico com justificada razão de publicação (raridade, aspectos inusitados, evoluções atípicas, inovações terapêuticas e de diagnóstico, entre outras). As secções serão, Introdução, Caso Clínico, Discussão, Bibliografia.O texto não deve exceder as 2.000 palavras e 25 referências bibliográficas. Deve ser acompanhado de figuras ilustrativas. O número de quadros/figuras não deve ser superior a 6.
All articles in this journal are Open Access under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0).
The names and addresses provided in this journal will be used exclusively for the services provided by this publication, and will not be made available for other purposes or to third parties.